Sterility Indicators Market
Sterility Indicators Market Analysis By Type (Biological, Chemical), By Sterilization Method (Heat, Low Temperature, Filtration, Liquid, Steam, Radiation), By End User (Hospitals, Pharmaceutical Companies, Medical Device Companies, Others), & By Region - Global Market Insights 2023 to 2033
Analysis of Sterility Indicators Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Sterility Indicators Market Outlook (2023 to 2033)
The global sterility indicators market is valued at US$ 1.07 billion in 2023. Worldwide sales of sterility indicators are predicted to increase at an impressive CAGR of 12.5% and reach a market valuation of US$ 3.47 billion in 2033.
Sterility indicators are classified into chemical and biological indicators. Global demand for chemical sterility indicators is expected to rise at a comparatively higher CAGR of 14% from 2023 to 2033.
Chemical sterility indicators are further segmented into class 1 to class 5 indicators. Indicators from classes 1 and 2 are often used in steam and ETO sterilization processes. Due to their expanding use, these indicators are anticipated to continue their dominance in the market over the forecast period. Tapes, strips, and other items are the subcategories of class 1 indicators.
Sales of biological sterility indicators are predicted to progress at a CAGR of 11% during the forecast period. Products including spore ampoules, spore suspensions, self-contained vials, and spore strips are all sub-segments of biological sterility indicators.
In contrast to chemical indicators, biological indicators provide accurate data. These are regarded as the industry's gold standard for evaluating sterilization. Compared to other types, spore ampoules are utilised a lot. They can be used in a variety of sterilization processes, including radiation sterilization, filtration sterilization, low-temperature sterilization, steam sterilization, and liquid sterilization.
Spores and a pH indicator are found in the ampoules. After the sterilization process, these indicators are incubated and examined for the presence of the acid that spores create.
Sterilization procedures are used to eliminate all living organisms as well as other external or biological agents that may be present, such as germs, viruses, fungi, pathogens, spore forms, etc. Different methods of sterilization include the use of heat, chemicals, radiation, high pressure, and filtration.
Global biological indicators incubators are used to eliminate bacterial growth and storage conditions. Lab incubators and microbiological incubators are two separate types of biological indicator incubators that are used for various purposes.
The biological indicator incubator eliminates pollution and offers better or more appropriate conditions for biological and chemical reactions. The biological indicator incubator helps to monitor it while the incubators maintain the ideal humidity, temperature, carbon dioxide, and oxygen contents of the interior atmosphere.
The market is expected to increase rapidly over the coming years due to rising R&D activities and advancements in the medical sector. In addition, it is projected that the demand for medicines and medical devices is likely to rise rapidly due to the increasing prevalence of chronic diseases such as cancer, diabetes, arthritis, and asthma.
| Report Attributes | Details |
|---|---|
| Market Size (2023E) | US$ 1.07 Billion |
| Forecasted Market Value (2033F) | US$ 3.47 Billion |
| Global Market Growth Rate (2023 to 2033) | 12.5% CAGR |
| China Market Growth Rate (2023 to 2033) | 16% CAGR |
| Japan Market Growth Rate (2023 to 2033) | 9% CAGR |
| Germany Market Growth Rate (2023 to 2033) | 10% CAGR |
| Key Companies Profiled | 3M Company; Anderson Products, Inc; Cantel Medical Corporation; Cardinal Health; Getinge Ab; GKE-GmbH; Hu-Friedy Mfg. Co., LLC; Matachana Group; Mesa Laboratories; Propper Manufacturing Co., Inc; Steris Plc |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Demand for Sterility Indicators Increasing across the World?
“Growing Risk of Hospital-acquired Infections”
Nosocomial infections, commonly referred to as hospital-acquired infections (HAIs), are contracted in hospitals, nursing homes, outpatient clinics, rehabilitation centers, or clinical settings. In clinical settings, there are several ways that infection is transmitted to susceptible patients.
Other sick patients, staff members, or environmental factors might all be the source of the infection. Nosocomial infections can commonly be caused by opportunistic bacteria that are the result of surgeries or any other medical procedures.
- The World Health Organization (WHO) estimates that, out of every 100 hospitalised patients, seven patients in industrialised countries and ten patients in developing countries would develop at least one hospital-acquired infection annually.
- According to the Healthcare Associated Infection Progress Report 2020 from the Centers for Disease Control and Prevention, there were roughly 18,416 surgical site infections recorded in the United States in 2020. In addition, it said that 2,173 of these infections occurred during hip arthroplasty and 6,094 occurred during colon surgery.
- According to the same source, in American hospitals, at least one in every 25 patients receives a diagnosis of HAI every year.
The market is expanding quickly due to the rising occurrence of surgical site infections and the consequent demand for HAI prevention solutions. The sales growth is increasing as awareness of sterility indicators' capacity to prevent infections in hospitals has improved. Therefore, biological indicators (BI) are crucial for sterilization quality control in hospitals because they can accurately determine whether the sterilizing conditions are ideal for eliminating the most resistant germs.
“Rising Prevalence of Infectious Diseases”
The prevalence of infectious diseases is increasing rapidly, recent COVID-19 pandemic has shown very adverse effects on society. Rising awareness by public and private organizations about infectious diseases, increasing investments in R&D activities, and advancements in medicines are boosting the demand for medical products for target infections.
- For instance, the World Health Organization's (WHO) Global Tuberculosis Report 2021 data shows that the majority of tuberculosis cases were found in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while the Eastern Mediterranean (8.3%), the Americas (3.0%), and Europe (2.3%) saw fewer rises in cases.
- According to the same source, Sub-Saharan Africa was estimated to continue to bear the brunt of malaria, which accounted for 96% of deaths of overall cases in 2021.
Over the past few years, the terminal sterilization market has drawn attention due to growing awareness of diseases and infections brought on by unsterile environments.
What is Negatively Influencing the Sales of Sterility Indicators?
“Increasing Risks Associated with Ethylene Oxide Sterilization Process”
Sales of sterility indicators could be hampered due to the increasing awareness of the side effects associated with the use of ethylene oxide. In particular, exposure to ethylene oxide has negative consequences on human health. It can irritate the eyes, nose, throat, lungs, and skin.
It is well known that acute exposure can cause a headache, nausea, vomiting, lung injuries, diarrhoea, breathing difficulties, and cyanosis. While prolonged exposure to ethylene oxide causes neurotoxicity, cancer, mutagenic alterations, and reproductive problems. These health hazards connected to using ethylene oxide for sterilization may restrain the market growth.
Additionally, flaws in sterility indicator equipment such as the inability to recognize procedural issues, challenging package configuration in the load, defective sterilization equipment, non-compliance with sterilization standards, high device costs, and chemical exposure hamper the demand for sterility indicators.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
Why is the North American Market Performing So Well?
“Presence of Key Market Players and Rising Cases of Chronic Disorders”
North America currently dominates the global market. U.S. and Canada both are expected to be profitable marketplaces for sterility indicator producers. Demand for sterility indicators is expected to increase at a high CAGR of 11% in Canada.
Standard product launches of pharmaceuticals, medical equipment, and biologics as well as positive reimbursement policies are booting the sales of sterility indicators in the region. The rapidly growing rate of the ageing target patient population, increasing cases of chronic diseases, and the presence of leading companies are driving regional market growth.
Will Europe be a Lucrative Market for Sterility Indicators?
“Presence of Advanced Healthcare Facilities and Rapid Development of Effective Solutions”
The Europe sterility indicators market is predicted to grow at a rapid pace during the forecast period. The U.K., Germany, France, and Italy are very beneficial countries for the medical tourism industry. Sales of sterility indicators are anticipated to rise at a CAGR of 10% during the next 10 years.
The availability of advanced healthcare facilities, the rising healthcare spending power of the population, and rising sterilization awareness are driving the growth of the regional market. The presence of numerous industry players who are committed to creating innovative, efficient solutions to enhance sterilization control in hospitals and pharmaceutical firms would improve the outlook for the regional market.
Where is Demand for Sterility Indicators Higher?
“Rapidly Advancing Medical Sector”
Asia Pacific is expected to be the fastest emerging market for sterility indicators. Local manufacturers are widely spread in China, South Korea, Japan, and India, and are providing affordable alternatives and escalating rivalry. The rapidly developing medical industry is attracting several target patients, availability of effective treatment at an effective cost boosts the regional market growth.
New biologics and sensitive goods are actively being developed by the biopharmaceutical industry. The bulk of treatments in newly commercialized biologics is designed in parenteral dose forms. It is anticipated that the rise in parenteral dosage manufacturing throughout the biopharmaceutical sector will generate new opportunities in the sterility indicators market in the Asia Pacific.
Category-wise Analysis
Which End User Accounts for High Sales of Sterility Indicators?
“Growing Levels of R&D Activities Performed in Pharmaceutical Companies”
Based on end users, the sterility indicators market is segmented into hospitals, pharmaceutical companies, medical device companies, and clinical laboratories/research centers.
Pharmaceutical companies currently hold more than 24% of revenue share as a result of the increasing rate of sterility testing as part of quality control during product manufacturing using sterility indicators.
Pharmaceutical businesses can test a wide range of applications using chemical and biological indicators. For instance, they use biological indicators in process challenge devices (PCD) for traditional autoclave sterilization testing, and the successful results demonstrate an efficient sterilization cycle. Pharmaceutical businesses are driving up demand for these products due to the rising level of R&D activities.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Some of the key players in the sterility indicators market are 3M Company, Anderson Products, Inc, Cantel Medical Corporation, Cardinal Health, Getinge Ab, GKE-GmbH, Hu-Friedy Mfg. Co., LLC, Matachana Group, and Mesa Laboratories.
To enter emerging markets including those in the Asia Pacific, the Middle East, and Africa, leading companies are working arduously to develop sophisticated, affordable indicators. Top market players are constantly utilizing new technologies to provide improved healthcare services through the introduction of smart indicators which follows the respective government’s norms.
- The Attest Mini Auto-reader 490M, a 24-minute in-house sterilization monitoring system, was introduced by the 3M company in July 2020. This technology is useful for the dental sterilization process.
Key Segments of Sterility Indicators Industry Research
-
By Type:
- Biological
- Chemical
-
By Sterilization Method:
- Heat
- Low Temperature
- Filtration
- Liquid
- Steam
- Radiation
-
By End User:
- Hospitals
- Pharmaceutical Companies
- Medical Device Companies
- Clinical Laboratories / Research Centers
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
- 6.1. Biological
- 6.2. Chemical
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Sterilization Method
- 7.1. Heat
- 7.2. Low Temperature
- 7.3. Filtration
- 7.4. Liquid
- 7.5. Steam
- 7.6. Radiation
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User
- 8.1. Hospitals
- 8.2. Pharmaceutical Companies
- 8.3. Medical Device Companies
- 8.4. Clinical Laboratories / Research Centers
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. 3M Company
- 17.2. Anderson Products, Inc
- 17.3. Cantel Medical Corporation
- 17.4. Cardinal Health
- 17.5. Getinge Ab
- 17.6. GKE-GmbH
- 17.7. Hu-Friedy Mfg. Co., LLC
- 17.8. Matachana Group
- 17.9. Mesa Laboratories
- 17.10. Propper Manufacturing Co., Inc
- 17.11. Steris Plc
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 2: Global Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 4: Global Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 5: Global Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Type, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Type, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Type, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Sterilization Method, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Sterilization Method, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Sterilization Method, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 4: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 5: Global Market Share and BPS Analysis by Type, 2023 & 2033
Figure 6: Global Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 7: Global Market Attractiveness Analysis by Type, 2023 to 2033
Figure 8: Global Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 9: Global Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Type, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Type, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Type, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Type, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Type, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Type, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Type, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Type, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Type, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Type, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Type, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Sterilization Method, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Sterilization Method, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Sterilization Method, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the market value of sterility indicators in 2023?
The global sterility indicators market is valued at US$ 1.07 billion in 2023.
What is the estimated growth rate for the sterility indicators market?
Global demand for sterility indicators is predicted to increase at an impressive CAGR of 12.5% through 2033.
What valuation is the sterility indicators market expected to reach by 2033?
Global sales of sterility indicators are projected to reach US$ 3.47 billion by 2033.
How will North America emerge as a lucrative avenue for the sterility indicators market?
Rapidly growing rate of the senior population and increasing cases of chronic disorders are boosting regional market growth.
Which companies form the competitive landscape of the sterility indicators industry?
3M Company, Anderson Products, Inc, Cantel Medical Corporation, and Cardinal Health are some of the leading companies in the market.
Sterility Indicators Market